Cargando…
Acquired-resistance of bevacizumab treatment for radiation brain necrosis: a case report
The case study reported on acquired bevacizumab resistance in one patient receiving re-treatment with bevacizumab following radiation brain necrosis progression after bevacizumab was discontinued. This case offers novel and additional insight for bevacizumab treatment. Low-dose bevacizumab is effect...
Autores principales: | Zhuang, Hongqing, Yuan, Xiangkun, Sun, Dayong, Bian, Jianliang, Chang, Joe Y., Yuan, Zhiyong, Wang, Ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4914358/ https://www.ncbi.nlm.nih.gov/pubmed/26933810 http://dx.doi.org/10.18632/oncotarget.7724 |
Ejemplares similares
-
Exploration of the recurrence in radiation brain necrosis after bevacizumab discontinuation
por: Zhuang, Hongqing, et al.
Publicado: (2016) -
Bevacizumab treatment for radiation brain necrosis: mechanism, efficacy and issues
por: Zhuang, Hongqing, et al.
Publicado: (2019) -
A study on the evaluation method and recent clinical efficacy of bevacizumab on the treatment of radiation cerebral necrosis
por: Zhuang, Hongqing, et al.
Publicado: (2016) -
Analysis of risk and predictors of brain radiation necrosis after radiosurgery
por: Zhuang, Hongqing, et al.
Publicado: (2015) -
MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma
por: Zhuang, Hongqing, et al.
Publicado: (2016)